Tuesday, 21 June 2016

Cancer Genome Sequencing 2016 Market Share,Size,Trends and Forecast to 2022 Market Research Report

WiseGuyReports.com adds“Cancer Genome Sequencing 2016 Market Share,Size,Trends and Forecast to 2022 Market Research Report”reports to its database.


Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations. This technique has proved to be a breakthrough in the fight against cancer as it assists in individualization of treatment. Development of new methods and exponential decrease in genome sequencing cost are fueling the market growth. Global cancer genome sequencing market is expected grow with a healthy CAGR due to technological advances and entry of new market players. Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences (Lincoln, NE), Abbott Laboratories, Beckman Coulter (Fullerton, CA), Bayer Corporation, Hamilton Thorne Biosciences, Integrated DNA Technologies, Microchip Biotechnologies, Myriad Genetics, Commonwealth Biotechnologies, ZS Genetics, and Pacific Biosciences are some of the key players of this market.

For more information or any query mail at sales@wiseguyreports.com  
   
The global cancer genome sequencing market is segmented on the basis of technology and geography. The currently technologies used include second generation and third generation platforms. Second generation technology platforms include SOLiD sequencing (by ABI), Pyro-sequencing (by Roche) and Bridge amplification sequencing technology (by Illumina). Third generation technology platform includes Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences), Ion semiconductor sequencing, Nanopore sequencing (by Oxford) and fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies). Geographically, the global cancer genome sequencing market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cancer genome sequencing market due to availability of advanced technologies and a skilled workforce. This market is driven by whole genome sequencing coupled with bioinformatics based sequencing technologies which provide personalized treatments for cancer.

KEY BENEFITS

This report offers the following benefits in particular:
Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cancer genome sequencing market
Porter’s Five Forces analysis examines the competitive structure of the global cancer genome sequencing market and would assist market strategists in their decision-making process.
In-depth coverage of the global cancer genome sequencing market including drivers, restraints and opportunities would help professionals to better understand market behavior
Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cancer genome sequencing market would be informative for professionals in the corporate sector 


KEY MARKET SEGMENTS

The global cancer genome sequencing market is segmented into two broad categories: technology and geography.

MARKET BY TECHNOLOGY

Second Generation Technology Platforms
SOLiD sequencing (by ABI)
Pyro-sequencing (by Roche)
Bridge amplification sequencing technology (by Illumina)
Third Generation Technology Platforms
Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences)
Ion semiconductor sequencing.
Nanopore sequencing (by Oxford)
fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies) 

MARKET BY GEOGRAPHY

North America
Europe
Asia-Pacific
LAMEA

RESEARCH METHODOLOGY

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
 
  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace
CONTINUE…….


For more information or any query mail at sales@wiseguyreports.com

Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

No comments:

Post a Comment